// App-Quantinova.ai

2761 : Cellular consequences of human tyrosyl-DNA phosphodiesterase I dysregulation

Researchers

Presenter

  • Selma M. Cuya

Principal Investigators

  • Kellie M. Regal

  • Robert C.A.M. Van Waardenburg

Medical Centers

  • University of Alabama at Birmingham, Birmingham, AL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Genetic Disorder

Disease

  • Seizures sensorineural deafness ataxia mental retardation electrolyte imbalance

  • Solid malignancies

  • Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1

Biomarkers

  • N/A

Drug/Treatment

  • Doxycycline

  • Irinotecan

  • Etoposide

  • Etoposide phosphate

  • Cisplatin

  • Topotecan Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved